Bone Growth

Acuitive Technologies Inc. announced FDA 510(k) clearance for Citrepore, a synthetic bioactive bone void filler designed to promote bone healing after orthopedic surgical procedures, according to a company press release.

Most transgender adolescents receiving a gonadotropin-releasing hormone agonist combined with gender-confirming hormone therapy grow to an adult height close to the reference height for their sex assigned at birth, according to study data.

Ventris Medical received FDA 510(k) clearance of its Amplify standalone bone graft putty, according to a company press release.

Vitamin D supplementation may be helpful for bone health, but the research is still undecided, according to an expert.

Biocomposites has announced its investee company Renovos Biologics has received FDA breakthrough device designation of its Renovite bone morphogenic protein-2 proprietary, synthetic, nanoclay bone fusion gel, according to a press release.

Theragen has announced the issuance of a second U.S. patent for its ActaStim-S, a wearable and app-compatible postoperative bone growth stimulator for patients undergoing spinal fusion, according to a release.

Subchondral Solutions Inc. has announced FDA 501(k) clearance for its S-Core implant platform, according to a press release.

Theragen Inc. has announced the issuance of a U.S. patent for the ActaStim-S, a spine fusion bone-growth stimulator system that reportedly promotes healing and encourages patient compliance during the postoperative process.

Teriparatide restores bone mineral quality to premenopausal levels for women with postmenopausal osteoporosis if taken for 24 months, but not if taken at shorter intervals, according to study findings published in Bone.

Serum levels of sex steroids and bone metabolism markers align with skeletal development in boys during puberty, though development can vary based on pubertal stage, according to study findings published in Bone.